In focus · trending topic

#clinical trial

9 stories · following the connections

Biothera Pharmaceuticals Commences Phase 2 Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)

By Nasdaq OMXFeb 6, 2018, 2:30 PM UTC

Biothera Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA in Non-Small Cell Lung Cancer

By Nasdaq OMXJul 19, 2017, 2:00 PM UTC

Biothera Pharmaceuticals Announces Presentation at the Upcoming 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

By Nasdaq OMXMay 31, 2017, 1:06 PM UTC

Biothera Pharmaceuticals Announces Presentation at the Upcoming 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

By Nasdaq OMXMay 31, 2017, 1:06 PM UTC

Biothera Pharmaceuticals Announces Presentation at the Upcoming 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

By Nasdaq OMXMay 31, 2017, 1:06 PM UTC

Biothera Pharmaceuticals Announces Presentation at the Upcoming 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

By Nasdaq OMXMay 31, 2017, 1:06 PM UTC

Biothera Pharmaceuticals Announces Presentation at the Upcoming 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

By Nasdaq OMXMay 31, 2017, 1:06 PM UTC

Biothera Pharmaceuticals Announces Presentation at the Upcoming 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

By Nasdaq OMXMay 31, 2017, 1:06 PM UTC